Title:
Botulinum toxin in management of neuroma pain: Case report

Simple item page
dc.contributor.authorA. Tiwari
dc.contributor.authorA.P. Singh
dc.contributor.authorR.K. Verma
dc.contributor.authorV. Rastogi
dc.contributor.authorR. Agrawal
dc.date.accessioned2026-02-07T04:44:13Z
dc.date.issued2006
dc.description.abstractNeuroma is a painful condition and always a challenging situation for pain clinicians. Botulinum toxin (BoNT) is a neurotoxin and it provides analgesia, possibly by inhibiting acetylcholine release or blocking autonomic pathways. We report two interesting cases of neuroma in which botulinum toxin (BoNT) serotype-A was locally infiltrated (10 units into the trigger point), three times after an interval of one month each. We observed relief of pain after 10 days and a complete remission after 4 months. © 2006 VSP.
dc.identifier.doi10.1163/156856906778026112
dc.identifier.issn1691112
dc.identifier.urihttps://doi.org/10.1163/156856906778026112
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/18547
dc.subjectAcetylcholine
dc.subjectBotulinum toxin
dc.subjectNeuroma
dc.subjectNeuropathic pain
dc.titleBotulinum toxin in management of neuroma pain: Case report
dc.typePublication
dspace.entity.typeArticle

Files

Collections

2006
An Initiative by BHU – Central Library
Powered by Dspace